Barclays analyst issues OVERWEIGHT recommendation for SHEL on October 5, 2026 04:10PM ET. The previous analyst recommendation was Overweight.SHEL was trading at $96.6 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current analyst recommendations are : 8 - Buy, 5 - Hold recommendations .Historical Analyst RecommendationsLatest 10 recommendationsReport DateAnalyst CompanyActionPrevious GradeNew GradePrice when...
from BNP Paribas issued a price target of $345.00 for NVDA on 2026-10-05 15:32:19.The adjusted price...
Patrick Colville from Scotiabank issued a price target of $615.00 for MSFT on 2026-10-05 14:03:04.The adjusted...
Exane BNP Paribas analyst issues OUTPERFORM recommendation for NVDA on October 5, 2026 03:32PM ET. The...
BMO Capital analyst issues OUTPERFORM recommendation for MSFT on October 5, 2026 01:44PM ET. The previous...
from BNP Paribas issued a price target of $345.00 for NVDA on 2026-10-05 15:32:19.The adjusted price target was set to $345.00.At the time of the announcement, NVDA was trading at...
Patrick Colville from Scotiabank issued a price target of $615.00 for MSFT on 2026-10-05 14:03:04.The adjusted price target was set to $615.00.At the time of the announcement, MSFT was trading...
Ben Reitzes from Melius Research issued a price target of $665.00 for MSFT on 2026-10-05 10:33:29.The adjusted price target was set to $665.00.At the time of the announcement, MSFT was...
from UBS issued a price target of $395.00 for JPM on 2026-10-05 10:20:51.The adjusted price target was set to $395.00.At the time of the announcement, JPM was trading at $332.38.The...
Michael Tyndall from HSBC issued a price target of $157.00 for TSLA on 2026-10-05 07:42:00.The adjusted price target was set to $157.00.At the time of the announcement, TSLA was trading...
In the first quarter of 2025, the company faced revenue declines, largely due to Paxlovid, while operational expenses surged. Management is committed to enhancing R&D productivity and optimizing capital allocation,...
In a bustling boardroom, executives reviewed a growth story marked by rising revenues, reaching $12,503 million, despite increasing operating expenses. Management celebrated a $342 million boost in service group revenues,...
In a landscape of growth, the company celebrated rising revenues, reaching $12,503 million, driven by strategic initiatives in high-demand sectors. Operating expenses were managed carefully, reflecting a commitment to efficiency....
In 2025, the company embraced growth through increased research and development, despite rising operating expenses. A net income of $24,780 million marked a decline, reflecting challenges in a fluctuating market....
In the first quarter of 2025, the company experienced a 9% revenue growth, fueled by increased sales and services. Operating expenses rose, reflecting evolving cost structures, while net income showed...
Apple and Tesla, two of the most innovative companies in the tech world, are both heavily investing in artificial intelligence (AI), yet their financial trajectories are starkly different. While Apple...
Recent developments highlight a significant disparity in the financial trajectories and market strategies of two titans of the tech industry: Apple Inc. and Tesla Inc. While both companies are heavily...
As concerns mount over the potential risks that artificial intelligence poses to humanity, Melius Research has positioned Microsoft Corporation as a pivotal player and a reassuring presence in the tech...
In September, Meta showcased its intensified focus on artificial intelligence (AI) by launching a series of innovative products and services designed to enhance its offerings and reinforce its position in...
The artificial intelligence (AI) investment landscape has experienced a significant shift, with the most popular AI exchange-traded fund (ETF) revealing an uncommon hierarchy among its holdings. Contrary to the general...
